Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On March 21, 2017, the Board of Directors of Ekso Bionics
Holdings, Inc. (the Company) voted to expand the number of
directors of the Company from seven to eight directors and
elected Howard D. Palefksy to serve as a director of the Company.
Mr. Palefksy will participate in the Companys standard
non-employee director compensation program. to this program, Mr.
Palefksy was awarded an option to purchase 28,571 shares of
common stock that becomes exercisable over a period of four
years. In addition, each non-employee director is entitled to
receive a $20,000 annual retainer and members of each standing
committee are entitled to receive an additional annual fee of
$10,000, except that the chairperson of the Compensation
Committee and the Nominating and Governance Committee receives an
annual fee of $15,000 and the chairperson of the Audit Committee
receives an annual fee of $30,000. At this time, Mr. Palefsky has
not been named to any committees of the Board of Directors.
It also is anticipated that Mr. Palefksy will enter into the
Companys standard indemnification agreement for directors of the
Company.
On March 23, 2017, the Company issued a press release announcing
the appointment of Mr. Palefsky. A copy of the press release is
filed with this Current Report on Form 8-K as Exhibit 99.1.
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| 99.1 | Press Release dated March 23, 2017 |
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Recent Trading Information
Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) closed its last trading session up +0.08 at 3.53 with 119,055 shares trading hands.
